Home | Business News | Browse by Publication | P | Pharma Marketletter

DOR gets $1.5M from Sigma under orBec deal.

Publication: Pharma Marketletter
Publication Date: 08-DEC-08
Format: Online
Delivery: Immediate Online Access
Full Article Title: DOR gets $1.5M from Sigma under orBec deal.(DOR BioPharma Inc.)(Sigma-Tau Pharmaceuticals Inc.)(Brief article)

Article Excerpt
USA-based DOR BioPharma has received $1.5 million from Sigma-Tau Pharmaceuticals as part of an agreement allowing the latter to negotiate terms and conditions for a possible business transaction or strategic alliance for orBec (oral beclomethasone dipropionate) and potentially other DOR pipeline compounds until March 2009.

Under the terms of...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Medicis and IMPAX settle over Solodyn, set up R&D accord., December 08, 2008
Sanofi-Aventis partners with Welvista to provide no-cost drugs., December 08, 2008
DIA meeting in India postponed.(Drug Information Association)(Brief ar..., December 08, 2008
Catalyst Biosciences raises $40 million., December 08, 2008
$1M Merck & Co research grant for NCCN., December 08, 2008

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.